Broadrick Dale's Form 4 filing
BioRestorative Therapies, Inc. (BRTX) · filed Mar 29, 2022
- Accession no.
- 0001567619-22-007664
- Filed
- Mar 29, 2022
- Trade date
- Mar 1-21, 2022
- Filing delay
- 28 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions. Open-market purchases total $794.1K. It was filed 28 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Broadrick DaleCIK 0001677513 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2022 | Common Stock | PPurchaseAcquired | +2,270 | $5.55 | +$12,598.5 | 201,984 | Indirect | |
| Mar 2, 2022 | Common Stock | PPurchaseAcquired | +47,840 | $5.61F2 | +$268,382.4 | 249,824 | Indirect | |
| Mar 3, 2022 | Common Stock | PPurchaseAcquired | +47,648 | $5.47F3 | +$260,634.56 | 297,472 | Indirect | |
| Mar 4, 2022 | Common Stock | PPurchaseAcquired | +3,800 | $5.51 | +$20,938 | 301,272 | Indirect | |
| Mar 7, 2022 | Common Stock | PPurchaseAcquired | +24,392 | $4.43F4 | +$108,056.56 | 175,853 | Direct | |
| Mar 8, 2022 | Common Stock | PPurchaseAcquired | +8,125 | $4.00 | +$32,500 | 183,978 | Direct | |
| Mar 9, 2022 | Common Stock | PPurchaseAcquired | +11,875 | $4.00 | +$47,500 | 195,853 | Direct | |
| Mar 21, 2022 | Common Stock | PPurchaseAcquired | +10,000 | $4.35 | +$43,500 | 205,853 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $5.56 to $5.62 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $5.39 to $5.60 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $3.97 to $4.53 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.